These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 30382619)

  • 61. Development and validation of plasma miRNA biomarker signature panel for the detection of early HIV-1 infection.
    Biswas S; Haleyurgirisetty M; Lee S; Hewlett I; Devadas K
    EBioMedicine; 2019 May; 43():307-316. PubMed ID: 31005516
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Plasma miRNA profile is a biomarker associated with urothelial carcinoma in chronic hemodialysis patients.
    Chen CL; Lin CH; Li AL; Huang CC; Shen BY; Chiang YR; Fang PL; Chang HC; Li KL; Yang WC; Horng JT; Ma N
    Am J Physiol Renal Physiol; 2019 Jun; 316(6):F1094-F1102. PubMed ID: 30892932
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Methylation of a panel of microRNA genes is a novel biomarker for detection of bladder cancer.
    Shimizu T; Suzuki H; Nojima M; Kitamura H; Yamamoto E; Maruyama R; Ashida M; Hatahira T; Kai M; Masumori N; Tokino T; Imai K; Tsukamoto T; Toyota M
    Eur Urol; 2013 Jun; 63(6):1091-100. PubMed ID: 23200812
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer.
    Zhang J; Song Y; Zhang C; Zhi X; Fu H; Ma Y; Chen Y; Pan F; Wang K; Ni J; Jin W; He X; Su H; Cui D
    Theranostics; 2015; 5(7):733-45. PubMed ID: 25897338
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A novel combination of serum microRNAs for the detection of early gastric cancer.
    Abe S; Matsuzaki J; Sudo K; Oda I; Katai H; Kato K; Takizawa S; Sakamoto H; Takeshita F; Niida S; Saito Y; Ochiya T
    Gastric Cancer; 2021 Jul; 24(4):835-843. PubMed ID: 33743111
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Aberrant expression of microRNAs in bladder cancer.
    Yoshino H; Seki N; Itesako T; Chiyomaru T; Nakagawa M; Enokida H
    Nat Rev Urol; 2013 Jul; 10(7):396-404. PubMed ID: 23712207
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dual tumor-suppressors miR-139-5p and miR-139-3p targeting matrix metalloprotease 11 in bladder cancer.
    Yonemori M; Seki N; Yoshino H; Matsushita R; Miyamoto K; Nakagawa M; Enokida H
    Cancer Sci; 2016 Sep; 107(9):1233-42. PubMed ID: 27355528
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Serum-based microRNA signatures in early diagnosis and prognosis prediction of colon cancer.
    Vychytilova-Faltejskova P; Radova L; Sachlova M; Kosarova Z; Slaba K; Fabian P; Grolich T; Prochazka V; Kala Z; Svoboda M; Kiss I; Vyzula R; Slaby O
    Carcinogenesis; 2016 Oct; 37(10):941-950. PubMed ID: 27485599
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Regulation of UHRF1 by dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p): Inhibition of bladder cancer cell aggressiveness.
    Matsushita R; Yoshino H; Enokida H; Goto Y; Miyamoto K; Yonemori M; Inoguchi S; Nakagawa M; Seki N
    Oncotarget; 2016 May; 7(19):28460-87. PubMed ID: 27072587
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Serum miR-210 Contributes to Tumor Detection, Stage Prediction and Dynamic Surveillance in Patients with Bladder Cancer.
    Yang Y; Qu A; Liu J; Wang R; Liu Y; Li G; Duan W; Fang Q; Jiang X; Wang L; Zheng G; Du L; Zhang X; Wang C
    PLoS One; 2015; 10(8):e0135168. PubMed ID: 26252880
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Identification of microR-106b as a prognostic biomarker of p53-like bladder cancers by ActMiR.
    Lee E; Collazo-Lorduy A; Castillo-Martin M; Gong Y; Wang L; Oh WK; Galsky MD; Cordon-Cardo C; Zhu J
    Oncogene; 2018 Nov; 37(44):5858-5872. PubMed ID: 29970902
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A novel urinary microRNA biomarker panel for detecting gastric cancer.
    Iwasaki H; Shimura T; Yamada T; Okuda Y; Natsume M; Kitagawa M; Horike SI; Kataoka H
    J Gastroenterol; 2019 Dec; 54(12):1061-1069. PubMed ID: 31240436
    [TBL] [Abstract][Full Text] [Related]  

  • 73. lncRNA TUC338 is a potential diagnostic biomarker for bladder cancer.
    Li G; Zhang Y; Mao J; Hu P; Chen Q; Ding W; Pu R
    J Cell Biochem; 2019 Oct; 120(10):18014-18019. PubMed ID: 31162712
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Altered Serum MicroRNA Profile May Serve as an Auxiliary Tool for Discriminating Aggressive Thyroid Carcinoma from Nonaggressive Thyroid Cancer and Benign Thyroid Nodules.
    Zhang A; Wang C; Lu H; Chen X; Ba Y; Zhang C; Zhang CY
    Dis Markers; 2019; 2019():3717683. PubMed ID: 31636734
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas.
    Yang C; Wang C; Chen X; Chen S; Zhang Y; Zhi F; Wang J; Li L; Zhou X; Li N; Pan H; Zhang J; Zen K; Zhang CY; Zhang C
    Int J Cancer; 2013 Jan; 132(1):116-27. PubMed ID: 22674182
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Expression of miR-100 as a novel ancillary non-invasive biomarker for early detection of bladder carcinoma.
    Qureshi A; Fahim A; Kazi N; Farsi Kazi SA; Nadeem F
    J Pak Med Assoc; 2018 May; 68(5):759-763. PubMed ID: 29885177
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Carboplatin with Decitabine Therapy, in Recurrent Platinum Resistant Ovarian Cancer, Alters Circulating miRNAs Concentrations: A Pilot Study.
    Benson EA; Skaar TC; Liu Y; Nephew KP; Matei D
    PLoS One; 2015; 10(10):e0141279. PubMed ID: 26485143
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Circulating microRNA124-3p, microRNA9-3p and microRNA196b-5p may be potential signatures for differential diagnosis of thyroid nodules.
    Yu S; Liu X; Zhang Y; Li J; Chen S; Zheng H; Reng R; Zhang C; Chen J; Chen L
    Oncotarget; 2016 Dec; 7(51):84165-84177. PubMed ID: 27705935
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Development and Validation of an Esophageal Squamous Cell Carcinoma Detection Model by Large-Scale MicroRNA Profiling.
    Sudo K; Kato K; Matsuzaki J; Boku N; Abe S; Saito Y; Daiko H; Takizawa S; Aoki Y; Sakamoto H; Niida S; Takeshita F; Fukuda T; Ochiya T
    JAMA Netw Open; 2019 May; 2(5):e194573. PubMed ID: 31125107
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Multi-analytical test based on serum miRNAs and proteins quantification for ovarian cancer early detection.
    Cirillo PDR; Margiotti K; Fabiani M; Barros-Filho MC; Sparacino D; Cima A; Longo SA; Cupellaro M; Mesoraca A; Giorlandino C
    PLoS One; 2021; 16(8):e0255804. PubMed ID: 34352040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.